﻿<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Mead Johnson Nutrition</title><link>http://www.meadjohnson.com</link><item><title>Mead Johnson Delivers 9 Percent Sales Growth; Reports Strong First Quarter Earnings; Raises Full-Year Guidance</title><link>http://www.meadjohnson.com/News/Pages/Release-1687715.aspx</link><description>GLENVIEW, Ill., Apr 26, 2012 (BUSINESS WIRE) --Mead Johnson Nutrition Company (NYSE: MJN) announced today its financial &lt;br&gt;   results for the first quarter ended March 31, 2012.&lt;br&gt;&lt;br&gt;&lt;br&gt; &lt;br&gt;   &lt;br&gt;    Net sales of $986.6 million in the quarter increased 9 percent versus &lt;br&gt;    the first quarter of 2011.&lt;br&gt;   &lt;br&gt;   &lt;br&gt;    GAAP net earnings of $0.80 per diluted share for the first quarter of &lt;br&gt;    2012 were up by 13 percent from $0.71 per diluted share a year ago.&lt;br&gt;   &lt;br&gt;   &lt;br&gt;    Non-GAAP(1) net earnings of...</description></item><item><title>Mead Johnson Schedules First Quarter Earnings Conference Call</title><link>http://www.meadjohnson.com/News/Pages/Release-1680623.aspx</link><description>GLENVIEW, Ill.--(BUSINESS WIRE)--Apr. 5, 2012--&lt;br&gt;   Mead Johnson Nutrition Company (NYSE: MJN) will release its first&lt;br&gt;   quarter 2012 earnings on Thursday, April 26, 2012, before the market&lt;br&gt;   opens. The company will host a conference call at 8:30 a.m. CDT that&lt;br&gt;   same day during which company executives will review first quarter&lt;br&gt;   financial results and respond to questions from analysts and investors.&lt;br&gt;  &lt;br&gt;&lt;br&gt;   The call will be broadcast over the Internet at meadjohnson.com.&lt;br&gt;   To...</description></item><item><title>Mead Johnson Nutrition and SanCor Complete Joint Venture</title><link>http://www.meadjohnson.com/News/Pages/Release-1673347.aspx</link><description>Alliance will serve and grow the pediatric nutrition market in South&lt;br&gt;   America’s Southern Cone, including Argentina, Chile, Paraguay, Uruguay&lt;br&gt;   and Bolivia&lt;br&gt;  &lt;br&gt;  BUENOS AIRES, Argentina &amp;amp; GLENVIEW, Ill.--(BUSINESS WIRE)--Mar. 15, 2012--&lt;br&gt;   Kasper Jakobsen, Mead Johnson Nutrition’s Chief Operating Officer (NYSE:&lt;br&gt;   MJN) and Oscar Carreras, Chairman of Board of Administration for SanCor&lt;br&gt;   Cooperativas Unidas Ltda. of Argentina, met today in Buenos Aires to&lt;br&gt;   officially...</description></item><item><title>Mead Johnson Board Increases Dividend by 15 Percent</title><link>http://www.meadjohnson.com/News/Pages/Release-1668682.aspx</link><description>GLENVIEW, Ill.--(BUSINESS WIRE)--Mar. 2, 2012--&lt;br&gt;   Mead Johnson Nutrition Company (NYSE: MJN) announced today that its&lt;br&gt;   board of directors had declared a regular quarterly common stock&lt;br&gt;   dividend of $0.30 per share for the quarter ending March 31, 2012, an&lt;br&gt;   increase of 15 percent from the prior rate of $0.26 per share, and&lt;br&gt;   expects the annualized dividend to be $1.20. The quarterly dividend will&lt;br&gt;   be paid on April 3, 2012, to shareholders of record at close of business&lt;br&gt;   on...</description></item><item><title>Mead Johnson Nutrition, SanCor Announce Plans for Joint Venture</title><link>http://www.meadjohnson.com/News/Pages/Release-1665064.aspx</link><description>Alliance will develop and market pediatric nutrition products for&lt;br&gt;   infants and children in South America’s Southern Cone, including&lt;br&gt;   Argentina, Chile, Paraguay, Uruguay and Bolivia&lt;br&gt;  &lt;br&gt;  BUENOS AIRES, Argentina &amp;amp; GLENVIEW, Ill.--(BUSINESS WIRE)--Feb. 24, 2012--&lt;br&gt;   Mead Johnson Nutrition (NYSE: MJN), a global leader in pediatric&lt;br&gt;   nutrition, and SanCor Cooperativas Unidas Ltda. of Argentina, the&lt;br&gt;   leading dairy producer in Argentina, today announced an undertaking in&lt;br&gt;  ...</description></item><item><title>Mead Johnson to Present at Annual Consumer Analyst Group of New York (CAGNY) Conference</title><link>http://www.meadjohnson.com/News/Pages/Release-1661655.aspx</link><description>GLENVIEW, Ill.--(BUSINESS WIRE)--Feb. 15, 2012--&lt;br&gt;   Mead Johnson Nutrition Company (NYSE: MJN) announced today that it will&lt;br&gt;   present at the 2012 Consumer Analyst Group of New York Conference in&lt;br&gt;   Boca Raton, Florida on Wednesday, February 22, 2012. The presentation by&lt;br&gt;   Kasper Jakobsen, executive vice president and chief operating officer&lt;br&gt;   and Peter G. Leemputte, executive vice president and chief financial&lt;br&gt;   officer, will begin at 1:45 p.m. EST and will be broadcast live over...</description></item><item><title>Mead Johnson Reports 17 Percent Sales Growth in 2011 and Delivers Non-GAAP EPS Growth of 15 Percent; Provides Initial 2012 Guidance</title><link>http://www.meadjohnson.com/News/Pages/Release-1653008.aspx</link><description>GLENVIEW, Ill.--(BUSINESS WIRE)--Jan. 26, 2012--&lt;br&gt;   Mead Johnson Nutrition Company (NYSE: MJN) announced today its financial&lt;br&gt;   results for the fourth quarter and year ended Dec. 31, 2011.&lt;br&gt;  &lt;br&gt;&lt;br&gt;   &lt;br&gt;    Net sales for 2011 were up 17 percent to $3,677.0 million from&lt;br&gt;    $3,141.6 million in 2010. Asia/Latin America grew 26 percent and North&lt;br&gt;    America/Europe grew 3 percent. Excluding the favorable impact of&lt;br&gt;    foreign exchange, sales increased 14 percent.&lt;br&gt;   &lt;br&gt;   &lt;br&gt;    GAAP net...</description></item><item><title>Mead Johnson Schedules Fourth Quarter Earnings Conference Call</title><link>http://www.meadjohnson.com/News/Pages/Release-1645367.aspx</link><description>GLENVIEW, Ill.--(BUSINESS WIRE)--Jan. 5, 2012--&lt;br&gt;   Mead Johnson Nutrition Company (NYSE: MJN) will release its fourth&lt;br&gt;   quarter 2011 earnings on Thursday, January 26, 2012, before the market&lt;br&gt;   opens. The company will host a conference call at 8:30 a.m. CST that&lt;br&gt;   same day during which company executives will review fourth quarter&lt;br&gt;   financial results and respond to questions from analysts and investors.&lt;br&gt;  &lt;br&gt;&lt;br&gt;   The call will be broadcast over the Internet at meadjohnson.com.&lt;br&gt;   To...</description></item><item><title>FDA and CDC Tests Confirm Enfamil PREMIUM(R) Newborn is Safe</title><link>http://www.meadjohnson.com/News/Pages/Release-1643142.aspx</link><description>Agencies Reaffirm Mead Johnson's Statements&lt;br&gt;   &lt;br&gt;&lt;br&gt;GLENVIEW, Ill., Dec 30, 2011 (BUSINESS WIRE) --Mead Johnson Nutrition (NYSE: MJN) was notified today by the United &lt;br&gt;   States Food &amp;amp; Drug Administration (FDA) and the Centers for Disease &lt;br&gt;   Control (CDC) that health inspectors have completed their testing on all &lt;br&gt;   formula samples collected from the company. These tests confirmed that &lt;br&gt;   the Mead Johnson products were safe, and no presence of Cronobacter &lt;br&gt;   was detected. This is...</description></item><item><title>FDA and CDC Tests Confirm Enfamil PREMIUM® Newborn is Safe</title><link>http://www.meadjohnson.com/News/Pages/Release-1643140.aspx</link><description>Agencies Reaffirm Mead Johnson's Statements&lt;br&gt;  &lt;br&gt;  GLENVIEW, Ill.--(BUSINESS WIRE)--Dec. 30, 2011--&lt;br&gt;   Mead Johnson Nutrition (NYSE: MJN) was notified today by the United&lt;br&gt;   States Food &amp;amp; Drug Administration (FDA) and the Centers for Disease&lt;br&gt;   Control (CDC) that health inspectors have completed their testing on all&lt;br&gt;   formula samples collected from the company. These tests confirmed that&lt;br&gt;   the Mead Johnson products were safe, and no presence of Cronobacter&lt;br&gt;   was detected. This...</description></item><item><title>New Tests Confirm Safety of Mead Johnson's Enfamil Premium Newborn Formula</title><link>http://www.meadjohnson.com/News/Pages/Release-1642621.aspx</link><description>GLENVIEW, Ill., Dec 25, 2011 (BUSINESS WIRE) --Mead Johnson Nutrition (NYSE: MJN) has conducted a new round of rigorous &lt;br&gt;   testing on samples of a batch of Enfamil Premium(R) Newborn powdered &lt;br&gt;   formula related to a U.S. Food &amp;amp; Drug Administration (FDA) &lt;br&gt;   investigation. Drawn from samples parallel to those being tested by &lt;br&gt;   public health officials and following the same methodology, the new &lt;br&gt;   testing did not detect any presence of Cronobacter (Enterobacter &lt;br&gt;  ...</description></item><item><title>New Tests Confirm Safety of Mead Johnson’s Enfamil Premium Newborn Formula</title><link>http://www.meadjohnson.com/News/Pages/Release-1642619.aspx</link><description>GLENVIEW, Ill.--(BUSINESS WIRE)--Dec. 25, 2011--&lt;br&gt;   Mead Johnson Nutrition (NYSE: MJN) has conducted a new round of rigorous&lt;br&gt;   testing on samples of a batch of Enfamil Premium® Newborn powdered&lt;br&gt;   formula related to a U.S. Food &amp;amp; Drug Administration (FDA)&lt;br&gt;   investigation. Drawn from samples parallel to those being tested by&lt;br&gt;   public health officials and following the same methodology, the new&lt;br&gt;   testing did not detect any presence of Cronobacter (Enterobacter&lt;br&gt;   sakazakii).&lt;br&gt; ...</description></item><item><title>Updated: Statement from Mead Johnson on Enfamil PREMIUM® Newborn Safety</title><link>http://www.meadjohnson.com/News/Pages/Release-1642617.aspx</link><description>For over 100 years Mead Johnson has been trusted by parents and healthcare professionals around the world to provide nutrition for their infants and children. That trust is earned based on the knowledge that every product we manufacture is safe and of the highest quality. All of our infant formula products sold around the world undergo more than 2,300 quality tests before they are shipped to retailers and other customers. Importantly, the standards we set always meet – and often exceed – those...</description></item><item><title>Statement from Mead Johnson on Enfamil Newborn Formula Safety</title><link>http://www.meadjohnson.com/News/Pages/Release-1642502.aspx</link><description>Our company recently became aware of an infant’s death in Missouri.  This infant tested positive for Cronobacter, which is a microorganism commonly found in the environment and sometimes implicated in rare but serious illnesses in newborn babies.  We were informed that the infant had been fed one of our products.  The product – Enfamil PREMIUM® Newborn powdered formula – has not been recalled, but is being tested by the U.S. Food and Drug Administration (FDA) with our assistance.  All of our...</description></item><item><title>Mead Johnson Donates Paintings to Evansville Museum</title><link>http://www.meadjohnson.com/News/Pages/Release-1641522.aspx</link><description>Evansville, Ind., December 20, 2011 – Mead Johnson Nutrition today announced a gift &lt;br&gt;of 14 important paintings to the Evansville Museum of Arts, History and Science.  The paintings are by the eminent 19th century Dutch artists Cornelis Zwaan and Bernard Pothast.  Featuring rural scenes of mothers caring for young children, prints of the paintings were originally used in calendars and other Mead Johnson publications.&lt;br&gt; &lt;br&gt;The donation was made during the Evansville Museum’s holiday board...</description></item><item><title>Mead Johnson Nutrition Announces Plans to Build Manufacturing Plant in Singapore</title><link>http://www.meadjohnson.com/News/Pages/Release-1637650.aspx</link><description>Company to make $325 million investment to meet future demand in Asia&lt;br&gt;  &lt;br&gt;  GLENVIEW, Ill.--(BUSINESS WIRE)--Dec. 7, 2011--&lt;br&gt;   Mead Johnson Nutrition (NYSE: MJN) today announced its decision to build&lt;br&gt;   a new manufacturing and technology center in Singapore. The project is&lt;br&gt;   the biggest capital expenditure in the company’s history and is needed&lt;br&gt;   to support future growth in its fast-growing business across the Asia&lt;br&gt;   region. The total project cost of $325 million is comprised of...</description></item><item><title>Mead Johnson Nutrition Announces Key Management Changes</title><link>http://www.meadjohnson.com/News/Pages/Release-1637649.aspx</link><description>Company creates new leadership roles, including Chief Operating&lt;br&gt;   Officer and Chief Development Officer&lt;br&gt;  &lt;br&gt;  GLENVIEW, Ill.--(BUSINESS WIRE)--Dec. 7, 2011--&lt;br&gt;   Mead Johnson Nutrition (NYSE: MJN) today announced a number of&lt;br&gt;   management changes designed to support the company’s ambitious,&lt;br&gt;   long-term growth strategy.&lt;br&gt;  &lt;br&gt;&lt;br&gt;   Kasper Jakobsen, currently the company’s President – Americas, will&lt;br&gt;   assume the newly created position of Executive Vice President &amp;amp; Chief&lt;br&gt;  ...</description></item><item><title>Mead Johnson Board Declares Dividend</title><link>http://www.meadjohnson.com/News/Pages/Release-1637583.aspx</link><description>GLENVIEW, Ill.--(BUSINESS WIRE)--Dec. 7, 2011--&lt;br&gt;   Mead Johnson Nutrition Company (NYSE: MJN) announced today that its&lt;br&gt;   board of directors had declared a regular quarterly common stock&lt;br&gt;   dividend of $0.26 per share for the quarter ending December 31, 2011.&lt;br&gt;   The dividend will be paid on January 3, 2012, to shareholders of record&lt;br&gt;   at close of business on December 19, 2011.&lt;br&gt;  &lt;br&gt;&lt;br&gt;   About Mead Johnson&lt;br&gt;  &lt;br&gt;&lt;br&gt;   Mead Johnson, a global leader in pediatric nutrition, develops,&lt;br&gt;  ...</description></item><item><title>Mead Johnson Nutrition Reports Strong Sales and Earnings; Third Quarter Constant Dollar Sales Up 11 Percent; Raises Full Year EPS Guidance</title><link>http://www.meadjohnson.com/News/Pages/Release-1622410.aspx</link><description>GLENVIEW, Ill., Oct 27, 2011 (BUSINESS WIRE) --Mead Johnson Nutrition Company (NYSE: MJN) announced today its financial &lt;br&gt;   results for the third quarter ended September 30, 2011.&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt; &lt;br&gt;  &lt;br&gt;    Net sales of $933.9 million in the quarter were up 15 percent versus &lt;br&gt;    the third quarter of 2010. Excluding the favorable impact of foreign &lt;br&gt;    exchange, sales increased 11 percent.&lt;br&gt;   &lt;br&gt;  &lt;br&gt;    GAAP net earnings of $0.70 per diluted share for the third quarter of &lt;br&gt;    2011 increased from...</description></item><item><title>Mead Johnson Schedules Third Quarter Earnings Conference Call</title><link>http://www.meadjohnson.com/News/Pages/Release-1619792.aspx</link><description>GLENVIEW, Ill., Oct 20, 2011 (BUSINESS WIRE) --Mead Johnson Nutrition Company (NYSE: MJN) will release its third &lt;br&gt;   quarter 2011 earnings on Thursday, October 27, 2011, before the market &lt;br&gt;   opens. The company will host a conference call at 8:30 a.m. CDT that &lt;br&gt;   same day during which company executives will review third quarter &lt;br&gt;   financial results and respond to questions from analysts and investors.&lt;br&gt;&lt;br&gt;&lt;br&gt;The call will be broadcast over the Internet at meadjohnson.com. &lt;br&gt;   To listen to...</description></item></channel></rss>
